论文部分内容阅读
本文观察了先服短效复方18甲、后改服减量长效复方18甲的已婚育龄妇女的ADP诱导血小板聚集程度、血浆纤维蛋白原、纤溶酶原及血清纤维蛋白原裂解产物(FDP)含量的变化,并以相似年龄的正常志愿者作为对照。结果:服全量长效复方18甲妇女的血小板聚集程度较服药前显著增加,但停药后恢复至正常水平,表明对血小板聚集程度的影响是可逆的。服减量长效复方18甲妇女的血小板聚集程度低于正常水平。无论服短效复方18甲还是服减量长效复方18甲三个月、半年时,纤维蛋白原含量均较对照组高,但服减量长效复方18甲一年后其含量恢复至正常范围。此外,服减量长效复方18甲妇女的纤溶酶原含量较对照组高,但FDP水平均在正常范围内。
This article observed the first service short-acting compound 18 A, after the service to reduce the long-acting compound weight 18 A married women of childbearing age ADP-induced platelet aggregation, plasma fibrinogen, plasminogen and serum fibrinogen ( FDP) content changes, and the normal age of normal volunteers as a control. Results: The total amount of long-acting compound 18 women with a platelet aggregation level increased significantly before taking medicine, but returned to normal levels after withdrawal, indicating that the degree of platelet aggregation is reversible. Serum reduction of long-acting compound 18 A women’s platelet aggregation level below normal. Regardless of short-acting compound 18 A or service reduction long-acting compound 18 A for three months, six months, fibrinogen levels were higher than the control group, but the service reduced dose long-acting compound 18 a year after its content returned to normal range. In addition, the reduction of long-acting compound 18 women with a plasminogen content higher than the control group, but FDP levels were within the normal range.